376 related articles for article (PubMed ID: 33121975)
1. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
Türkoğlu G; Berkem R; Karakoç AE
Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
[TBL] [Abstract][Full Text] [Related]
5. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
6. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
La Jeon Y; Kang SY; Lee WI; Kim MH
Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
[TBL] [Abstract][Full Text] [Related]
7. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M
Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
9. High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA).
Seelig CA; Blüthner M; Seelig HP
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390377
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.
Shovman O; Gilburd B; Chayat C; Amital H; Langevitz P; Watad A; Guy A; Perez D; Azoulay D; Blank M; Segal Y; Bentow C; Mahler M; Shoenfeld Y
Clin Exp Rheumatol; 2018; 36(1):121-126. PubMed ID: 28770702
[TBL] [Abstract][Full Text] [Related]
11. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
Mahler M; Hanly JG; Fritzler MJ
Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
[TBL] [Abstract][Full Text] [Related]
12. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
Peker BO; Şener AG; Tarhan EF; Kaya S
Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
[TBL] [Abstract][Full Text] [Related]
13. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the Clinical Significance of Anti-Dense Fine Speckled 70 (anti-DFS70) Autoantibody and Determination of Accompanying Pathologies].
Çetin Duran A; Barut K; Duran A; Eren Dağlar D
Mikrobiyol Bul; 2021 Jul; 55(3):415-425. PubMed ID: 34416806
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.
Mahler M; Fritzler MJ
Clin Dev Immunol; 2012; 2012():494356. PubMed ID: 23304189
[TBL] [Abstract][Full Text] [Related]
16. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
[TBL] [Abstract][Full Text] [Related]
17. A novel magnetic bead-based immunoprecipitation method for anti-dense fine speckled 70 antibodies.
Chen R; Wei X; Yang C; Nguyen K
Pathology; 2023 Oct; 55(6):843-849. PubMed ID: 37336684
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan.
Hayashi N; Uto K; Imanishi A; Sugiyama D; Morinobu A; Saegusa J
Medicine (Baltimore); 2021 Mar; 100(9):e24556. PubMed ID: 33655922
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort.
Carbone T; Pafundi V; Tramontano G; Gilio M; Padula MC; Padula AA; D'Angelo S
Sci Rep; 2019 Feb; 9(1):2177. PubMed ID: 30778125
[TBL] [Abstract][Full Text] [Related]
20. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]